PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.045
-0.155 (-12.92%)
At close: Oct 6, 2026, 4:00 PM EDT
1.030
-0.015 (-1.44%)
After-hours: Oct 6, 2026, 7:59 PM EDT
PDS Biotechnology Employees
PDS Biotechnology had 21 employees as of December 31, 2025. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$1,603,427
Market Cap
58.49M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 21 | -3 | -12.50% |
| Dec 31, 2024 | 24 | -1 | -4.00% |
| Dec 31, 2023 | 25 | -1 | -3.85% |
| Dec 31, 2022 | 26 | 4 | 18.18% |
| Dec 31, 2021 | 22 | 7 | 46.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Fractyl Health | 100 |
| Alps Group | 93 |
| Clene | 79 |
| Xilio Therapeutics | 76 |
| Connect Biopharma Holdings | 64 |
| Mereo BioPharma Group | 39 |
| Boundless Bio | 28 |
PDSB News
- 13 hours ago - PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases - GlobeNewsWire
- 14 days ago - PDS announces publication of results from Phase 2 trial of PDS0101 - TheFly
- 14 days ago - PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology - GlobeNewsWire
- 15 days ago - PDS Biotechnology Slides: Corporate presentation - Filings
- 22 days ago - PDS Biotechnology announces initial closing of up to $22.3M PIPE financing - TheFly
- 22 days ago - PDS Biotechnology names Soon-Shiong, James Banaag to board of directors - TheFly
- 22 days ago - PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors - GlobeNewsWire
- 4 weeks ago - PDS Biotechnology price target lowered to $5 from $7 at H.C. Wainwright - TheFly